Caption Management, LLC Travere Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$5.44 - $9.5 $2.09 Million - $3.66 Million	-385,000 Reduced 92.33%	32,000 $287,000
Q3 2023 Nov 14, 2023	BUY	$7.64 - $17.25 $3.19 Million - $7.19 Million	417,000 New	417,000 $3.73 Million
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $2.86 Million - $3.58 Million	125,000 New	125,000 $3.08 Million
Q1 2022 May 13, 2022	SELL	$23.61 - $30.6 $590,250 - $765,000	-25,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$24.34 - $31.17 $3.04 Million - $3.9 Million	-125,000 Reduced 83.33%	25,000 $775,000

Q3 2021 Nov 12, 2021	BUY	$12.98 - $25.03 $280,368 - $540,648	21,600 Added 16.82%	150,000 $3.64 Million
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $1.81 Million - $3.39 Million	128,400 New	128,400 $1.87 Million

184

89.5M

66.9K

265K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $506M
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.